In our experiments, the enhanced E-cadherin expression as well as the reduced expression of Snail, Vimentin, and N-cadherin also suggested that knockdown of ABRACL inhibited the EMT process in breast cancer cells, which was in line with the above study. This evidence concerns the gene ABRACL and breast carcinoma.